Abstract
A 61-year-old-female with a 4-year history of disseminated granuloma annulare was successfully treated with the antitumor necrosis factor (TNF)-alpha antibody, adalimumab. The patient had failed high potency topical glucocorticoids, hydroxychloroquine, and narrow-band ultraviolet light (UV)-B phototherapy. Anti-TNF-alpha therapy may be a therapeutic option in patients with disseminated granuloma annulare poorly controlled with conventional medications.
| Original language | English |
|---|---|
| Pages (from-to) | 169-171 |
| Number of pages | 3 |
| Journal | Journal of Drugs in Dermatology |
| Volume | 8 |
| Issue number | 2 |
| State | Published - Feb 2009 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Successful treatment of disseminated granuloma annulare with adalimumab'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver